AY20 Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Aytu Biopharma Inc

Watchlist Manager

Watchlist

Price: 3.279 EUR

Market Cap: €18.3m

A	Aytu Biopharma Inc F:AY20	US
E	Eurofins Scientific SE DUS:ESF0	LU
R	Renta 4 Banco SA F:4RE	ES

Profitability Summary

Aytu Biopharma Inc's profitability score is 29/100. We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

67%

Strong 3Y Average Gross Margin

67%

Gross Margin is Increasing

62% > 67%

Negative Operating Margin

-1%

Negative 3Y Average Operating Margin

-3%

Operating Margin is Increasing

-11% > -1%

Negative Net Margin

-39%

Negative 3Y Average Net Margin

-17%

Declining Net Margin

-16% > -39%

Negative Free Cash Flow Margin

-6%

Negative 3Y Average Free Cash Flow Margin

-2%

Declining Free Cash Flow Margin

-5% > -6%

Negative ROE

-109%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-3%

ROIC is Increasing

-12% > -1%

View All

Hide

Collapse

29 / 100

Profitability
Score

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.